Targeting breast cancer with rationally designed quinazolines: A scaffold hopping strategy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Kwanshik | - |
dc.contributor.author | Nada, Hossam | - |
dc.contributor.author | Gul, Anam Rana | - |
dc.contributor.author | Elkamhawy, Ahmed | - |
dc.contributor.author | Al-Karmalawy, Ahmed A. | - |
dc.contributor.author | Park, Tae Jung | - |
dc.contributor.author | Lee, Kyeong | - |
dc.contributor.author | Choi, Yongseok | - |
dc.date.accessioned | 2024-07-12T06:00:28Z | - |
dc.date.available | 2024-07-12T06:00:28Z | - |
dc.date.issued | 2024-11 | - |
dc.identifier.issn | 0022-2860 | - |
dc.identifier.issn | 1872-8014 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74722 | - |
dc.description.abstract | A novel series of 4-anilinoquinazoline derivatives obtained from a scaffold hopping strategy was designed and synthesized as anticancer agents. Among the synthesized derivatives, compound 5h displayed the best anticancer activity against MCF7 and MDA-MB-231 breast cancer cells, with IC50 values of 0.35 μM and 0.45 μM, respectively. Notably, these values were more potent than those of the FDA approved erlotinib, which had IC50 values of 3.571 μM and 0.546 μM for MCF7 and MDA-MB-231, respectively. Mechanistic studies revealed 5h arrested cell cycle in the G2/M phase induced apoptosis more effectively than erlotinib. Further investigations into the mode of action of the synthesized derivatives included EGFR and HER2 kinase assays. Reverse virtual screening and in silico mechanistic studies were carried out to elucidate the activity of the synthesized derivatives. The findings underscore the potential of these novel derivatives, particularly compound 5h, as promising candidates for further development as anticancer agents. © 2024 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier B.V. | - |
dc.title | Targeting breast cancer with rationally designed quinazolines: A scaffold hopping strategy | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.molstruc.2024.138805 | - |
dc.identifier.bibliographicCitation | Journal of Molecular Structure, v.1315 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 001256719800001 | - |
dc.identifier.scopusid | 2-s2.0-85195429962 | - |
dc.citation.title | Journal of Molecular Structure | - |
dc.citation.volume | 1315 | - |
dc.type.docType | Article | - |
dc.publisher.location | 네델란드 | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.subject.keywordAuthor | Breast cancer | - |
dc.subject.keywordAuthor | Quinazoline | - |
dc.subject.keywordAuthor | Scaffold hopping | - |
dc.subject.keywordAuthor | Synthesis | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | LIBRARY | - |
dc.subject.keywordPlus | EGFR | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Physical | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.